Stock listing
Axim Biotechnologies, Inc.
Selected listing: AXIM · OTC · USD · US
Axim Biotechnologies, Inc. (OTC:AXIM), Health Technology. Latest release Oct 6, 2026: AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid…
- Ticker
- OTC:AXIM
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- OTC
- Currency
- USD
About Axim Biotechnologies, Inc.
Axim Biotechnologies, Inc. is a public company traded under the ticker AXIM in the American market. Axim focuses on biotechnological innovations and solutions.
Latest news from Axim Biotechnologies, Inc.
AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease
October 6, 2026
Medical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
January 29, 2026
AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
January 29, 2026
AXIM Biotechnologies Engages 624 Advisors, Owned and Managed by Dr. Alan J. Touch, Innovator and Global Regulatory Leader, as Chief Medical & Regulatory Affairs Advisor
January 20, 2026
AXIM Biotechnologies, Inc. Announces Exclusive Distribution Agreement With VisionPlus Corp. for TearScan(R) Lactoferrin and IgE Diagnostic Tests in South Korea
October 23, 2025
Research Axim Biotechnologies, Inc.
Axim Biotechnologies, Inc. company profile
View the public company page for Axim Biotechnologies, Inc. on 6ix.
Axim Biotechnologies, Inc. news
Read company news and market updates connected to Axim Biotechnologies, Inc..
Axim Biotechnologies, Inc. investor events
Find investor webinars, events, and replay context for Axim Biotechnologies, Inc..